Reviewed by:
Prescription required
Diltiazem Hydrochloride is a prescription medication used to treat high blood pressure, chest pain (angina), and certain heart rhythm disorders, such as atrial fibrillation or flutter. It relaxes the heart and blood vessel muscles, improving blood flow and lowering blood pressure. Available in immediate- and extended-release forms, Cardizem may be prescribed alone or with other cardiovascular medications.
Ready to Fill
Diltiazem
Cardizem, Cardizem CD, Cardizem LA, Cartia XT, Tiazac
Calcium channel blocker (antihypertensive, antianginal, antiarrhythmic)
Not a controlled medication
Tablets (immediate-release), capsules (extended-release), intravenous (IV) solution.
For hypertension, oral therapy typically begins at 180–240 mg once daily, with gradual increases up to 480 mg daily as needed. In chronic stable or variant angina, usual dosing ranges from 120–180 mg once daily, adjusted based on response. For arrhythmias, IV dosing commonly starts at 0.25 mg/kg administered over 2 minutes, followed by 0.35 mg/kg if needed, and then a continuous infusion as directed.
Basics
Diltiazem is a prescription medication classified as a calcium channel blocker, commonly used to treat high blood pressure (hypertension), angina (chest pain), and certain heart rhythm disorders.
By relaxing blood vessels and slowing electrical conduction through the heart, diltiazem improves blood flow, lowers blood pressure, and helps control heart rate. These effects reduce cardiac strain and help prevent complications, such as heart attacks and worsening arrhythmias.
Diltiazem is well absorbed from the gastrointestinal tract and undergoes first-pass hepatic metabolism. It is available in both immediate-release and extended-release formulations, allowing clinicians to tailor dosing schedules to individual cardiovascular needs.
Note: This medication’s generic and brand-name formulations are used interchangeably throughout this article.
Cardizem is the brand-name formulation of diltiazem and contains the same active ingredient as the generic versions. It is prescribed for the same cardiovascular indications, including hypertension, angina, and certain arrhythmias.
Cardizem is available in specific immediate-release and extended-release formulations designed to provide consistent blood levels and predictable control of heart rate and blood pressure.
While Cardizem and generic diltiazem are therapeutically equivalent, patients should remain on the specific formulation prescribed, as switching between different release types can affect symptom control.
Indications
Cardizem is a calcium channel blocker prescribed to manage several cardiovascular conditions that affect heart function and blood pressure. By relaxing cardiac and vascular muscle, Cardizem improves blood flow, reduces cardiac workload, and stabilizes the heart rhythm in specific clinical scenarios.
Cardizem is primarily indicated for the following conditions:
Although not approved by the FDA for these purposes, Cardizem may also be prescribed off-label in certain medical contexts, including:
Off-label prescribing is based on clinical experience, patient-specific considerations, and close medical supervision. Decisions to use Cardizem outside of approved indications should always be made collaboratively between healthcare providers and patients.
Mechanism
The mechanism behind Cardizem’s efficacy lies in its ability to block calcium ions from entering the vascular smooth muscle and myocardial cells.
By inhibiting calcium currents, Cardizem reduces the strength of heart muscle contractions, relaxing blood vessels. This lowers blood pressure and eases the workload on the heart, which can benefit patients with hypertension and angina. Regulation of calcium flow also helps control heart rate, which is particularly useful in treating arrhythmias.
Cardizem’s action as a calcium channel blocker prevents calcium-induced vascular contraction, thereby promoting vasodilation. This opens up the arteries, reduces peripheral resistance, and enhances the delivery of oxygen-rich blood to the heart muscle. Together, these effects help prevent the chest pain associated with angina and stabilize heart rhythms.
Understanding Cardizem’s pharmacokinetic profile can help healthcare providers fine-tune dosages and monitor patient responses, thereby achieving optimal therapeutic outcomes.
Cardizem is extensively metabolized in the liver, where it undergoes first-pass metabolism, decreasing its bioavailability to 30–40%. That’s still sufficient to exert a therapeutic effect, particularly in the maintenance treatment of chronic conditions.
The extended-release (ER) forms of Cardizem are designed to provide steady plasma concentrations for once-daily dosing that remains effective for 24 hours. This is critical for conditions requiring consistent blood pressure control and heart rate management.
Excretion of Cardizem’s metabolic by-products happens primarily through urine and feces. The metabolism of Cardizem requires careful consideration in patients with hepatic impairment, as hepatic function is required for its processing.
Dosage
The dosage and administration of Cardizem depend on the individual patient and condition being treated, and should be determined by a licensed medical provider.
For hypertension, the typical starting dose of Cardizem is around 180 mg once daily, with adjustments made based on patient response and tolerance.
In angina management, the dosage may range up to 360 mg per day, administered as divided doses or once daily with extended-release products.
For arrhythmias, the dosage may be adjusted to stabilize heart rate more aggressively, necessitating precise dosing by a healthcare professional.
In pediatric use or less common off-label treatments, dosing must also be delicately balanced and personalized. Dosage adjustments are often necessary to accommodate patient-specific factors such as age, body weight, and concurrent medical conditions.
Generally, it is advised to take Cardizem on an empty stomach, as food can interfere with the drug’s bioavailability. Additionally, maintaining a consistent dosing schedule is crucial for effective management of blood pressure and heart rate.
Extended-release forms, indicated by suffixes such as CD, LA, or ER, should be swallowed whole and not crushed or chewed to preserve their controlled-release mechanism.
Patients on Cardizem should closely follow their healthcare provider’s instructions, monitor for changes in symptoms or side effects, and report them promptly. Regular follow-up appointments and blood tests may be necessary to ensure that the medication is effective and does not cause adverse effects.
Why pay retail prices for the same medication?
At Invictus, we source directly from trusted, FDA-approved manufacturers to keep your costs low without sacrificing quality. Whether you need a one-time fill or regular refills, our transparent pricing makes it easy to save every day.
Side Effects
Cardizem is generally well tolerated; however, like all cardiovascular medications, it can cause a range of side effects. These may be mild and self-limiting or, in some cases, clinically significant. Understanding potential reactions helps patients and healthcare providers monitor safety and adjust treatment when needed.
Common side effects of Cardizem include:
Although most common side effects resolve with continued use, patients are encouraged to notify their healthcare provider if symptoms persist or worsen. Adjusting the dosage or switching formulations may provide relief.
More severe side effects are uncommon but require immediate medical attention:
Prompt recognition of serious adverse effects enables timely intervention, which may include dose reduction, temporary discontinuation, or alternative therapy.
Interactions
Cardizem interacts with a variety of medications, and these interactions may alter its plasma levels, increase the risk of side effects, or affect the efficacy of other drugs. A thorough medication review is essential before starting or adjusting Cardizem therapy.
Cardizem has several clinically significant interactions:
Additional factors can influence Cardizem’s action:
Maintaining open communication with healthcare providers ensures safer medication regimens and optimal therapeutic outcomes.
Contraindications
Certain medical conditions make Cardizem inappropriate or unsafe. Identifying these contraindications helps prevent serious complications and guides clinicians in selecting safer alternatives.
Cardizem should not be used in individuals with:
Certain patient populations require special monitoring:
Ongoing evaluation of cardiac and liver function, along with a thorough review of comorbid conditions, supports safe long-term use of Cardizem.
The information provided on this page is for general informational purposes only and is not intended as medical advice. Always consult with a licensed healthcare provider before starting, stopping, or changing any medication regimen. While Invictus strives to provide accurate and up-to-date information, individual health conditions and circumstances vary. The prices, availability, and descriptions of all medications on this page are subject to change.
Your Prescription
Ready to Fill
Need Help?